🗣️🗣️🗣️ Llegó el día!! Desde hoy están abiertas las inscripciones a nuestro #MOOC de @abiertaUGR de @CanalUGR sobre Mosquitos, enfermedades y cambio global en 👉🏻 https://t.co/PQ9HJH74Zp El curso cuenta con 5 módulos que vamos desgranando 👇🏻🧵 #gratuito#ECTS
Host preference and human blood index of Phlebotomus orientalis, an exophilic sand fly vector of visceral leishmaniasis in eastern Sudan: https://t.co/y3Wd54RUUR
#InsectVectors#Phlebotomus#SandFly#Leishmaniasis
Our 2023Sep issue https://t.co/cbi2BSoKXJ reviews kinase inhibitors as antimalarial, plant-parasitic nematode effectors, helminth & RheumaticDiseases, host stable isotopes, MalariaControl in Bangladesh, Leishmania epidemiology in Brazil&Spain, & zoonotic risks of InvasiveWildlife
Really happy to see our latest paper published (the 1st of my thesis😁)!! We assessed the effect of #antibiotic exposure of #Culex pipiens #mosquitoes during larval and adult stages on adult survival rate, obtaining very interesting results! Check it out⬇️https://t.co/5LFgkSVTrY
Em 2013, a @pahowho criou recomendações para o tratamento das leishmanioses na Região das Américas. Mas, diante das evidências acumuladas desde então, foi preciso revisá-las. Esta 2a edição apresenta as novas recomendações👇
https://t.co/mcQli6eBwJ
Hoy es viernes de...#SEMTSICHALLENGE
❓Que enfermedad sospecharias
1⃣Lepra
2⃣ Sifilis
3⃣ Leishmaniasis
La respuesta mas tarde en nuestra cuenta...🕕
Imagen: CDC/ Arthur E. Kayne
#ISNTDConnect Novel approaches for fighting leishmaniasis - from Computer-aided drug design approaches to development of a Novel Cost-Effective Oral Amphotericin B Formulation to Treat #Leishmaniasis
In case you missed it - REPLAY https://t.co/3OsG9k7QwB
La @CanalUGR organiza un curso online de Machine Mearning y Big data para la #bioinformatica. El curso es gratuito y empieza el 6 de Febrero. Muy recomendable!!! Tenéis mas información en: https://t.co/H6Ys0hQm5K #MOOCml_bioinformatica
.@WHO is hiring an intern (students and recent graduates) for Epidemic and Pandemic Preparedness and Prevention in Geneva, Switzerland for a 12-week duration - June-August 2023.
Un equipo formado por el @CSIC y Zendal ha desarrollado una vacuna contra la leishmaniasis canina basada en ADN recombinante, que reduce la presencia del parásito en más de un 90% y mejora los signos clínicos de la enfermedad.
https://t.co/AlLdPiSrDd